Arjun Medical Group

Why It Matters

The addition of an in‑person DPPE expands access to evidence‑based diabetes prevention in Manhattan, targeting patients who lack Medicare coverage and may benefit from direct lifestyle coaching.

Key Takeaways

• In‑person DPPE offered at 120 E 36th St, NYC
• Accepts referrals from RH, expanding patient pipeline
• Does not accept Medicare, limiting coverage options
• Part of DP Alliance network, program ID DPPE‑640

Pulse Analysis

Diabetes remains a leading chronic condition in the United States, with the CDC estimating over 34 million Americans living with the disease. Preventive interventions such as the Diabetes Prevention Program (DPP) have demonstrated a 58% reduction in progression to type 2 diabetes among high‑risk participants. The DPPE variant—Diabetes Prevention Program Education—focuses on structured lifestyle coaching delivered either virtually or in‑person. While virtual formats have surged post‑pandemic, many clinicians argue that face‑to‑face sessions improve engagement, accountability, and long‑term behavior change, especially in densely populated urban neighborhoods.

Arjun Medical Group’s new DPPE offering, listed under program ID DPPE‑640, situates the service at 120 E 36th St in Manhattan’s Midtown East. The clinic accepts referrals from RH, a regional health network, creating a direct pipeline for patients identified through primary‑care screenings. Notably, the program does not accept Medicare reimbursement, signaling a focus on privately insured or self‑pay participants. This limitation may restrict access for seniors and low‑income adults, but it also allows the practice to avoid Medicare’s administrative overhead and tailor services to a higher‑margin payer mix.

The inclusion of Arjun Medical Group in the DP Alliance network highlights a growing ecosystem of providers standardizing DPPE delivery. As insurers increasingly recognize the cost‑saving potential of preventive care, partnerships between health systems and independent clinics are expected to expand. Providers that can demonstrate measurable outcomes—weight loss, HbA1c reduction, and sustained lifestyle changes—will attract value‑based contracts and possibly qualify for future Medicare Advantage incentives. For patients in New York City, the new in‑person option adds a convenient, evidence‑based pathway to curb diabetes risk.